Skip to content
Recall Observatory FDA recall evidence

Drug product

buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceutical Industries Limited, Gujrat, India, NDC 47335-737-86

D-0761-2023

May 09, 2023

Class II

Product summary

Firm
SUN PHARMACEUTICAL INDUSTRIES INC
Event
Event 92289
Status
Terminated
Classification
Class II
Quantity
5,344 Bottles
Official record key
drug-enforcement:D-0761-2023

Official wording

Reason: Failed Dissolution Specifications; during stability testing

Code information: Lots: HAC2240A, Exp 05/2023; HAC3162A, Exp 07/2023

Distribution pattern: Nationwide in the U.S.A

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications